Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis
Andrea Faggiano, Elisa Gherbesi, Chiara Giordano, Giacomo Gamberini, Marco Vicenzi, Cesare Cuspidi, Stefano Carugo, Carlo M Cipolla, Daniela M Cardinale, Andrea Manni · 2024
Read Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis by Andrea Faggiano, Elisa Gherbesi, Chiara Giordano, Giacomo Gamberini, Marco Vicenzi, Cesare Cuspidi, Stefano Carugo, Carlo M Cipolla, Daniela M Cardinale, Andrea Manni (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592457.txt.
Description
Andrea Faggiano and co-authors pool studies on quiet heart damage from breast cancer drugs in a 2024 review. Anthracycline chemotherapy can weaken the heart's right chamber before any symptoms show. Catching that slide early could spare survivors a second disease.
Across fifteen studies with 1,148 patients, every measure of right chamber function fell after treatment. The sensitive strain measures, which track how the muscle deforms, dropped clearest and most steadily. Older simple measures wobbled between studies. The right side's decline did not simply mirror the left side's pumping score, so it needs its own watch. The authors back strain checks as routine follow-up for these patients.
Catalog record
| CREATOR | Andrea Faggiano, Elisa Gherbesi, Chiara Giordano, Giacomo Gamberini, Marco Vicenzi, Cesare Cuspidi, Stefano Carugo, Carlo M Cipolla, Daniela M Cardinale, Andrea Manni |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |